Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aspen Pharmacare stock logo
APNHY
Aspen Pharmacare
$6.99
+3.3%
$6.69
$5.76
$13.69
N/A0.96248 shs122 shs
CHME
China Medicine
$0.00
$0.00
$0.00
$0.01
N/A213.3375 shsN/A
Globeimmune, Inc. stock logo
GBIM
Globeimmune
$0.00
$0.00
$0.00
$0.00
N/A-269.17N/A410 shs
IPAH
Interpharm
$0.00
$0.00
$0.00
N/A59.47N/AN/A
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aspen Pharmacare stock logo
APNHY
Aspen Pharmacare
0.00%+2.91%+1.81%-6.66%-44.29%
CHME
China Medicine
0.00%0.00%+50.00%+200.00%+200.00%
Globeimmune, Inc. stock logo
GBIM
Globeimmune
0.00%0.00%-50.00%-50.00%-50.00%
IPAH
Interpharm
0.00%0.00%0.00%0.00%+4,000.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Aspen Pharmacare stock logo
APNHY
Aspen Pharmacare
N/AN/AN/AN/AN/AN/AN/AN/A
CHME
China Medicine
N/AN/AN/AN/AN/AN/AN/AN/A
Globeimmune, Inc. stock logo
GBIM
Globeimmune
N/AN/AN/AN/AN/AN/AN/AN/A
IPAH
Interpharm
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aspen Pharmacare stock logo
APNHY
Aspen Pharmacare
0.00
N/AN/AN/A
CHME
China Medicine
0.00
N/AN/AN/A
Globeimmune, Inc. stock logo
GBIM
Globeimmune
0.00
N/AN/AN/A
IPAH
Interpharm
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aspen Pharmacare stock logo
APNHY
Aspen Pharmacare
$2.39BN/AN/AN/AN/AN/A
CHME
China Medicine
N/AN/AN/AN/AN/AN/A
Globeimmune, Inc. stock logo
GBIM
Globeimmune
N/AN/AN/AN/AN/AN/A
IPAH
Interpharm
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aspen Pharmacare stock logo
APNHY
Aspen Pharmacare
$235.61MN/A0.006.92N/AN/AN/AN/A9/3/2025 (Estimated)
CHME
China Medicine
N/AN/A0.00N/AN/AN/AN/AN/A
Globeimmune, Inc. stock logo
GBIM
Globeimmune
N/AN/A0.00N/AN/AN/AN/AN/A
IPAH
Interpharm
N/AN/A0.00N/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Aspen Pharmacare stock logo
APNHY
Aspen Pharmacare
$0.121.72%N/AN/AN/A
CHME
China Medicine
N/AN/AN/AN/AN/A
Globeimmune, Inc. stock logo
GBIM
Globeimmune
N/AN/AN/AN/AN/A
IPAH
Interpharm
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aspen Pharmacare stock logo
APNHY
Aspen Pharmacare
0.36
2.35
1.25
CHME
China Medicine
N/AN/AN/A
Globeimmune, Inc. stock logo
GBIM
Globeimmune
N/AN/AN/A
IPAH
Interpharm
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Aspen Pharmacare stock logo
APNHY
Aspen Pharmacare
N/A
CHME
China Medicine
N/A
Globeimmune, Inc. stock logo
GBIM
Globeimmune
N/A
IPAH
Interpharm
N/A

Insider Ownership

CompanyInsider Ownership
Aspen Pharmacare stock logo
APNHY
Aspen Pharmacare
N/A
CHME
China Medicine
29.70%
Globeimmune, Inc. stock logo
GBIM
Globeimmune
23.50%
IPAH
Interpharm
58.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Aspen Pharmacare stock logo
APNHY
Aspen Pharmacare
9,350N/AN/ANot Optionable
CHME
China Medicine
280N/AN/ANot Optionable
Globeimmune, Inc. stock logo
GBIM
Globeimmune
3N/AN/ANot Optionable
IPAH
Interpharm
670N/AN/ANot Optionable

Recent News About These Companies

No headlines for this company have been tracked by MarketBeat.com

Media Sentiment Over Time

Aspen Pharmacare stock logo

Aspen Pharmacare OTCMKTS:APNHY

$6.99 +0.22 (+3.27%)
As of 07/3/2025

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.

China Medicine OTCMKTS:CHME

$0.0003 0.00 (0.00%)
As of 07/3/2025

China Medicine Corporation produces and distributes prescription and over the counter drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. The company offers various products for applications, including oncology, high blood pressure, and removal of toxins from food and animal feeds. It provides products that treat stagnation of the heart blood, obstruction of qi in the chest, cardiodynia, headache, and dysmenorrhea; upper respiratory tract infection, acute faucitis, acute tonsillitis, acute gastroenteritis, etc.; acute and chronic hepatitis, deferment hepatitis, cholecystitis, etc.; irregular menstruation, dysmenorrhea, and amenorrhea; anemia and deficiency of vital energy; palpitation, dizziness, and fatigue; and cerebral arteriosclerosis and ischemic stroke. The company distributes its products through a sales network in China. The company was formerly known as Lounsberry Holdings III, Inc. and changed its name to China Medicine Corporation in May 2006. China Medicine Corporation was founded in 2005 and is based in Guangzhou, China.

Globeimmune stock logo

Globeimmune OTCMKTS:GBIM

$0.0001 0.00 (0.00%)
As of 07/7/2025 11:34 AM Eastern

GlobeImmune, Inc., a biopharmaceutical company, focuses on developing therapeutic products for cancer and infectious diseases based on proprietary Tarmogen platform. Its product candidate includes GS-4774, which is in Phase 2 trials for the treatment of patients with chronically infected with hepatitis B virus, as well as with oral antiviral suppressive therapy. The company is also involved in developing GI-6301 for the treatment of cancers expressing the brachyury protein; and GI-6207 that is in Phase 2 clinical trials to treat medullary thyroid cancer. In addition, it is involved in developing GI-4000, which is in Phase 2b clinical trials for the treatment of resected pancreas cancer; and is in Phase 2 clinical trial to treat non-small cell lung cancer, as well as is in Phase 2 clinical trial for the treatment of colorectal cancer. Further, the company is involved in developing various other product candidates targeting various infectious diseases that are in preclinical development stage, which include GI-19000 to treat tuberculosis; GI-2010 for the treatment of human immunodeficiency virus; and GI-18000 for hepatitis D virus infection. It has strategic collaborations with Gilead Sciences, Inc. and Celgene Corporation. The company was formerly known as Ceres Pharmaceuticals, Inc. and changed its name to GlobeImmune, Inc. in May 2001. GlobeImmune, Inc. was founded in 1995 and is headquartered in Louisville, Colorado. GlobeImmune, Inc. operates as a subsidiary of ImmunityBio, Inc.

Interpharm OTCMKTS:IPAH

Interpharm Holdings, Inc. develops, manufactures, and markets generic prescription strength and over-the-counter pharmaceuticals. The company supplies its medicines to major retailers, wholesalers, managed care organizations, and national distributors. The company was founded in 1984 and is based in Hauppauge, New York.